Yuyan Zheng

921 total citations
29 papers, 435 citations indexed

About

Yuyan Zheng is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Nephrology. According to data from OpenAlex, Yuyan Zheng has authored 29 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 9 papers in Nephrology. Recurrent topics in Yuyan Zheng's work include Lung Cancer Diagnosis and Treatment (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Chronic Kidney Disease and Diabetes (3 papers). Yuyan Zheng is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Chronic Kidney Disease and Diabetes (3 papers). Yuyan Zheng collaborates with scholars based in China, Canada and United States. Yuyan Zheng's co-authors include Hecheng Li, Chengqiang Li, Xiaohong Chen, Jian Li, Shengguang Zhao, Antoon Lerut, Kai Chen, Xijia Feng, Yuquan Wu and Yichao Han and has published in prestigious journals such as PLoS ONE, Kidney International and CHEST Journal.

In The Last Decade

Yuyan Zheng

26 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuyan Zheng China 11 225 202 136 95 35 29 435
Y Kadotani Japan 10 103 0.5× 114 0.6× 47 0.3× 63 0.7× 30 0.9× 35 345
Hiroomi Nakatsu Japan 13 124 0.6× 411 2.0× 87 0.6× 34 0.4× 75 2.1× 45 552
Sumit Dahal United States 11 141 0.6× 33 0.2× 76 0.6× 29 0.3× 18 0.5× 40 395
Hiroyuki Watanabe Japan 13 72 0.3× 93 0.5× 217 1.6× 18 0.2× 69 2.0× 37 414
Pui–Ching Lee Taiwan 10 142 0.6× 61 0.3× 63 0.5× 22 0.2× 26 0.7× 13 732
Myung Han Hyun South Korea 9 79 0.4× 52 0.3× 43 0.3× 31 0.3× 49 1.4× 24 373
Xiang He China 10 93 0.4× 54 0.3× 57 0.4× 65 0.7× 45 1.3× 19 390
Artur Oliver Spain 8 109 0.5× 91 0.5× 20 0.1× 72 0.8× 59 1.7× 11 381
Ankit Mangla United States 10 63 0.3× 73 0.4× 156 1.1× 12 0.1× 41 1.2× 74 332
Amanda Tchakarov United States 8 27 0.1× 137 0.7× 260 1.9× 90 0.9× 32 0.9× 34 405

Countries citing papers authored by Yuyan Zheng

Since Specialization
Citations

This map shows the geographic impact of Yuyan Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuyan Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuyan Zheng more than expected).

Fields of papers citing papers by Yuyan Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuyan Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuyan Zheng. The network helps show where Yuyan Zheng may publish in the future.

Co-authorship network of co-authors of Yuyan Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuyan Zheng. A scholar is included among the top collaborators of Yuyan Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuyan Zheng. Yuyan Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yuyan, et al.. (2025). TG-FTIR analysis of co-pyrolysis behavior between petroleum coke and model lignocellulosic biomass. Journal of the Energy Institute. 122. 102223–102223.
2.
Holmes, Daniel T., Mark Canney, Ognjenka Djurdjev, et al.. (2024). Assessing Discharge Communication and Follow-up of Acute Kidney Injury in British Columbia: A Retrospective Chart Review. Canadian Journal of Kidney Health and Disease. 11. 1035177264–1035177264. 2 indexed citations
3.
Zheng, Yuyan, Jingjing Zhang, Chao Chen, et al.. (2024). Prophylactic hyperthermic intraperitoneal chemotherapy in T4 colorectal cancer: Can it improve the oncologic prognosis? – A propensity score matching study. European Journal of Surgical Oncology. 50(2). 107958–107958.
4.
Zheng, Yuyan, Xinyi Wang, Chengqiang Li, et al.. (2024). Margin quality analysis for wedge resection of lung cancer and construction of a predictive model. Translational Lung Cancer Research. 13(3). 540–551. 1 indexed citations
5.
Canney, Mark, Mohammad Atiquzzaman, Yuyan Zheng, et al.. (2024). Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseases. Kidney International. 107(1). 143–154. 1 indexed citations
6.
Huang, Yuying, Xiuhua Hu, Xiaoqin Zhang, et al.. (2024). PnNAC2 promotes the biosynthesis of Panax notoginseng saponins and induces early flowering. Plant Cell Reports. 43(3). 73–73. 1 indexed citations
7.
Jin, Runsen, Yuyan Zheng, Yuqin Cao, et al.. (2023). Health-Related Quality of Life Following Robotic-Assisted or Video-Assisted Lobectomy in Patients With Non-Small Cell Lung Cancer. CHEST Journal. 163(6). 1576–1588. 19 indexed citations
8.
Canney, Mark, et al.. (2023). Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study. American Journal of Kidney Diseases. 82(6). 725–736. 2 indexed citations
9.
Zheng, Yuyan, et al.. (2023). Minimum chi-square method for estimating population size in capture-recapture experiments. PLoS ONE. 18(10). e0292622–e0292622. 1 indexed citations
11.
Canney, Mark, Mohammad Atiquzzaman, Yuyan Zheng, et al.. (2022). A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination. Journal of the American Society of Nephrology. 33(12). 2247–2257. 36 indexed citations
12.
Canney, Mark, et al.. (2022). The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases. American Journal of Kidney Diseases. 80(6). 740–750. 21 indexed citations
15.
Li, Chengqiang, et al.. (2021). Augmented reality navigation-guided pulmonary nodule localization in a canine model. Translational Lung Cancer Research. 10(11). 4152–4160. 10 indexed citations
16.
Cao, Zhujun, Yuyan Zheng, Yajie Zhang, et al.. (2021). A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests. Frontiers in Physiology. 12. 642922–642922. 13 indexed citations
17.
Zheng, Yuyan, Chengqiang Li, Bentong Yu, et al.. (2021). Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design. JTCVS Open. 9. 293–299. 16 indexed citations
18.
Jin, Runsen, Yuyan Zheng, Yajie Zhang, et al.. (2021). A nomogram for preoperative prediction of prolonged air leak after pulmonary malignancy resection. Translational Lung Cancer Research. 10(8). 3616–3626. 10 indexed citations
19.
Li, Chengqiang, Shengguang Zhao, Yuyan Zheng, et al.. (2020). Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1). European Journal of Cancer. 144. 232–241. 201 indexed citations
20.
Hu, Liming, et al.. (2015). Design, synthesis, and biological activity of phenyl-pyrazole derivatives as BCR–ABL kinase inhibitors. Bioorganic & Medicinal Chemistry. 23(13). 3147–3152. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026